CD19 and acute lymphoblastic leukemia: Similarly, they observed that CAR T cells with specificity to CD19 and a T cell-signaling molecule resulted in durable remission of acute lymphoblastic leukemia (ALL) in two pediatric patients with refractory and relapsed pre-B cell ALL [65].